Cervical Neoplasm
14
1
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
Study of AK112 in the Treatment of Advanced Gynecological Tumors
HARE-40: HPV Anti-CD40 RNA vaccinE
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Colposcopy and Dynamic Spectral Imaging (DSI)
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity
HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study
Chinese Cancer Prevention Study(CHICAPS)
The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru